Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/012790 stock hub

KOSDAQ/012790 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/012790is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
68.5B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/012790
In the news

Latest news · KOSDAQ/012790

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E9.1
P25 n/aP50 n/aP75 n/a
ROE5
P25 n/aP50 n/aP75 n/a
ROIC5.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/012790 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
219
Groups with data
11
Currency
KRW
Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
South Korea
Country code
KR
Employees
287
Enterprise value
KRW 29.6B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
KRW 68.5B
Price
KRW 6,020
Price currency
KRW
Rev Per Employee
280,709,545.3x
Sic
2834
Symbol
kosdaq/012790
Website
https://www.sinilpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
11%
EV Earnings
3.92x
EV/EBIT
4x
EV/EBITDA
2.21x
EV/FCF
3.5x
EV/Sales
0.37x
FCF yield
12.33%
P/B ratio
0.45x
P/E ratio
9.09x
P/S ratio
0.85x
PE Ratio10 Y
12.78x
PE Ratio3 Y
6.41x
PE Ratio5 Y
11.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
9.17%
EBITDA Margin
16.6%
FCF margin
10.48%
Gross margin
41.5%
Gross Profit
KRW 33.4B
Gross Profit Growth
-17.78%
Gross Profit Growth Q
-29.85%
Gross Profit Growth3 Y
-2.11%
Gross Profit Growth5 Y
6.68%
Net Income
KRW 7.5B
Net Income Growth
-47.34%
Net Income Growth Q
-96.6%
Net Income Growth3 Y
-14.75%
Net Income Growth5 Y
-0.04%
Pretax Margin
10.67%
Profit Margin
9.35%
Profit Per Employee
KRW 26.2M
ROA
2.75
Roa5y
4.97
ROCE
4.77
ROE
5.04
Roe5y
8.42
ROIC
5.69
Roic5y
9.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

22
MetricValue
Cagr10y
-5.42%
Cagr15y
10.21%
Cagr1y
-7.1%
Cagr20y
6.91%
Cagr3y
-7.37%
Cagr5y
-14.15%
Div CAGR10
7.68%
Div CAGR3
3.78%
Div CAGR5
14.59%
FCF Growth
-31.5%
FCF Growth Q
39.61%
FCF Growth3 Y
36.28%
FCF Growth5 Y
30.16%
OCF Growth
-48.92%
OCF Growth Q
-47.09%
OCF Growth10 Y
1.94%
OCF Growth3 Y
-5.4%
OCF Growth5 Y
0.94%
Revenue Growth
-9.93x
Revenue Growth Q
-1.9x
Revenue Growth3 Y
0.23x
Revenue Growth5 Y
5.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
KRW 0.48
Assets
KRW 169.5B
Cash
KRW 39.2B
Current Assets
KRW 82.6B
Current Liabilities
KRW 14.7B
Debt
KRW 283.2M
Debt EBITDA
KRW 0.02
Debt Equity
KRW 0
Debt FCF
KRW 0.03
Equity
KRW 152.3B
Interest Coverage
374.7
Liabilities
KRW 17.1B
Long Term Assets
KRW 86.9B
Long Term Liabilities
KRW 2.5B
Net Cash
KRW 38.9B
Net Cash By Market Cap
KRW 56.85
Net Cash Growth
16.98%
Net Debt EBITDA
KRW -2.91
Net Debt Equity
KRW -0.26
Net Debt FCF
KRW -4.61
Tangible Book Value
KRW 150B
WACC
7.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.63
Inventory Turnover
2.05
Net Working Capital
KRW 28.8B
Quick ratio
4.06
Working Capital
KRW 67.9B
Working Capital Turnover
KRW 1.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
KRW 190
Dividend Years
26
Dividend Yield
3.16%
Ex Div Date
2025-12-29
Last Dividend
KRW 190
Payout Frequency
Annual
Payout Ratio
29.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-42.71%
1Y total return
-7.1%
200-day SMA
6,153.5
3Y total return
-20.52%
50-day SMA
6,127
50-day SMA vs 200-day SMA
50under200
5Y total return
-53.35%
All Time High
52,658.5
All Time High Change
-88.57%
All Time High Date
2020-07-23
All Time Low
456.6
All Time Low Change
1,218.42%
All Time Low Date
2000-10-31
ATR
136.2
Beta
0.58
Beta1y
0.22
Beta2y
0.29
Ch YTD
-0.82
High
6,060
High52
7,200
High52 Date
2025-05-22
High52ch
-16.39%
Low
5,990
Low52
5,640
Low52 Date
2025-11-05
Low52ch
6.74%
Ma50ch
-1.75%
Price vs 200-day SMA
-2.17%
RSI
38.85
RSI Monthly
42.23
RSI Weekly
46.82
Sharpe ratio
-0.47x
Sortino ratio
-0.39
Total Return
3.16%
Tr YTD
-0.82
Tr15y
329.85%
Tr1m
0.67%
Tr1w
-2.27%
Tr3m
4.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
KRW 7.4B
Operating Income Growth
-51.48
Operating Income Growth3 Y
-18.53
Operating Income Growth5 Y
2.21
Operating margin
9.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
7,464,769%
Net Borrowing
-149,489,250
Shares Insiders
34.33%
Shares Institutions
0.36%
Shares Out
11,376,271

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
KRW 8.4B
Average Volume
27,143.15x
CAPEX
KRW -3.1B
Ch10y
-49.6
Ch15y
248.3
Ch1m
0.67
Ch1w
-2.27
Ch1y
-7.1
Ch20y
176.8
Ch3m
4.33
Ch3y
-24.56
Ch5y
-56.57
Ch6m
5.25
Change
-0.5%
Change From Open
-0.66
Close
6,050
Days Gap
0.17
Depreciation Amortization
5,991,086,710
Dollar Volume
146,749,540
Earnings Date
2026-03-03
EBIT
KRW 7.4B
EBITDA
KRW 13.4B
F Score
5
FCF
KRW 8.4B
FCF EV Yield
28.57x
FCF Per Share
KRW 742
Financing CF
-2,123,805,840
Fiscal Year End
December
Founded
1,971
Income Tax
KRW 1.1B
Investing CF
-4,802,511,930
Is Primary Listing
1
Last Earnings Date
2026-03-03
Last Report Date
2025-12-31
Last Split Date
2022-12-28
Last Split Type
Forward
Ma150
6,051.9
Ma150ch
-0.53%
Ma20
6,252
Ma20ch
-3.71%
Net CF
4,669,938,320
Open
6,060
P FCF Ratio
8.11
P OCF Ratio
5.91
Payment Date
2026-04-30
Position In Range
42.86
Ppne
42,645,132,510
Price Date
2026-05-08
Price EBITDA
KRW 5.12
Ptbv Ratio
0.46
Relative Volume
0.9x
Revenue
80,563,639,500x
Tax By Revenue
1.32x
Tax Rate
12.41%
Tr20y
280.73%
Tr6m
5.25%
Volume
24,377
Z Score
4.85
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KOSDAQ/012790 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.2%
$190 annual per share
Payout ratio
+29.2%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+14.6%
0 consecutive years of growth
Total shareholder yield
+3.2%
Next ex-dividend date: 2025-12-29
Performance

KOSDAQ/012790 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-7.1%
S&P 500 1Y: n/a
3Y total return
-20.5%
S&P 500 3Y: n/a
5Y total return
-53.3%
S&P 500 5Y: n/a
10Y total return
-42.7%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/012790?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.4%
Share of float held by funds and institutions
Insider ownership
+34.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

KOSDAQ/012790 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.9
Neutral momentum band
Price vs 200-day MA
-2.2%
50/200-day relationship not available
Beta (5Y)
0.58
Less volatile than the market
Sharpe ratio
-0.47
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/012790

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/012790 stock rating?

kosdaq/012790 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/012790 analysis?

The full report lives at /stocks/kosdaq/012790/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/012790?

The latest report frames kosdaq/012790 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/012790 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

kosdaq/012790 stock profile: metrics, valuation and analysis | Hisse Senedi Piyasası AI Ajanı